Spirig’s products treat conditions such as solar damage and skin barrier function impairment. In addition, the company has a range of medically-proven products that prevent pre-cancerous conditions, such as actinic keratosis, a type of non-melanoma skin cancer. Leading brands include Excipial, Daylong and Daylong Actinica. Based in Egerkingen, Spirig is the leader in dermatology in Switzerland. With 390 employees, Spirig generated sales of approximately $105 million in 2011.